1. Anti-MRSA cephems. Part 2: C-7 cinnamic acid derivatives
- Author
-
Dane M, Springer, Bing Yu, Luh, Jason, Goodrich, and Joanne J, Bronson
- Subjects
Lethal Dose 50 ,Disease Models, Animal ,Mice ,Staphylococcus aureus ,Structure-Activity Relationship ,Cinnamates ,Toxicity Tests, Acute ,Animals ,Methicillin Resistance ,Microbial Sensitivity Tests ,Staphylococcal Infections ,Anti-Bacterial Agents ,Cephalosporins - Abstract
Forty-five novel cephalosporin derivatives with activity against methicillin-resistant Staphylococcus aureus (MRSA) are described. The compounds contain novel cinnamic acid moieties at C-7 that were synthesized using a key Heck reaction followed by nucleophilic aromatic substitution reactions. The most active compound (41) displayed an MIC(90) against MRSA of 1.0 microg/mL, and a PD(50) of 0.8 mg/kg. Compound 14 was found to be very safe in a mouse model of acute toxicity.
- Published
- 2002